Published in N Engl J Med on March 27, 1997
Solid cancers after allogeneic hematopoietic cell transplantation. Blood (2008) 2.56
Quality of life after allogeneic hematopoietic cell transplantation. Blood (2009) 2.49
Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol (2011) 2.31
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach. Nat Rev Clin Oncol (2012) 2.05
A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction. Phys Med Biol (2008) 1.89
Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. Blood (2012) 1.81
Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood (2005) 1.73
Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies. Blood (2010) 1.62
Interleukin-22: immunobiology and pathology. Annu Rev Immunol (2015) 1.60
Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol (2010) 1.48
Busulfan in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2009) 1.46
Principles of bone marrow transplantation (BMT): providing optimal veterinary and husbandry care to irradiated mice in BMT studies. J Am Assoc Lab Anim Sci (2009) 1.39
Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. Blood (2010) 1.38
How I treat late effects in adults after allogeneic stem cell transplantation. Blood (2010) 1.26
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood (2002) 1.26
Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party. Blood (2007) 1.22
New approaches for preventing and treating chronic graft-versus-host disease. Blood (2005) 1.20
Contribution of HIV infection to mortality among cancer patients in Uganda. AIDS (2013) 1.19
Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention. Br J Haematol (2009) 1.19
Cancer incidence and survival following bereavement. Am J Public Health (2000) 1.17
Thyroid function following hematopoietic cell transplantation in children: 30 years' experience. Blood (2008) 1.17
Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning. Biol Blood Marrow Transplant (2014) 1.15
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol (2013) 1.13
Roles of the immune system in skin cancer. Br J Dermatol (2011) 1.12
p53 mediates senescence-like arrest induced by chronic replicational stress. Mol Cell Biol (2007) 1.11
Direct injection of autologous mesenchymal stromal cells improves myocardial function. Biochem Biophys Res Commun (2009) 1.08
Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD. Clin Oral Investig (2010) 1.06
Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission. Biol Blood Marrow Transplant (2007) 1.02
Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation. Cytotherapy (2012) 1.01
Combinations of immunotherapy and radiation in cancer therapy. Front Oncol (2014) 1.01
Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study. BMC Infect Dis (2013) 0.98
A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas. Br J Cancer (2009) 0.98
Donor-derived second hematologic malignancies after cord blood transplantation. Biol Blood Marrow Transplant (2010) 0.98
Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Leukemia (2010) 0.97
Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes. Bone Marrow Transplant (2011) 0.96
Can routine posttransplant HPV vaccination prevent commonly occurring epithelial cancers after allogeneic stem cell transplantation? Clin Cancer Res (2009) 0.96
Granulocyte colony-stimulating factor-producing esophageal squamous cell carcinoma following chemoradiotherapy and bone marrow transplantation for acute lymphoblastic leukemia. Esophagus (2013) 0.93
Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up. Expert Rev Hematol (2011) 0.93
Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation. Radiat Res (2009) 0.92
Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia. Curr Opin Oncol (2009) 0.91
Ionizing radiation and hematopoietic malignancies: altering the adaptive landscape. Cell Cycle (2010) 0.91
Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplant. J Immunother Cancer (2015) 0.90
Second cancer after total-body irradiation (TBI) in childhood. Strahlenther Onkol (2009) 0.90
A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia. Clin Lymphoma Myeloma Leuk (2014) 0.89
Replicational stress selects for p53 mutation. Cell Cycle (2007) 0.89
Direct and indirect contribution of bone marrow-derived cells to cancer. Int J Cancer (2010) 0.88
Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review. Med Oncol (2009) 0.88
Risk of radiation-related salivary gland carcinomas among survivors of Hodgkin lymphoma: a population-based analysis. Cancer (2008) 0.87
Long-term adverse effects of hematopoietic stem cell transplantation on dental development in children. Support Care Cancer (2009) 0.87
Subsequent malignant neoplasms after hematopoietic cell transplantation. Biol Blood Marrow Transplant (2012) 0.87
Oral carcinoma after hematopoietic stem cell transplantation--a new classification based on a literature review over 30 years. Head Neck Oncol (2009) 0.86
Enhancing T cell reconstitution after hematopoietic stem cell transplantation: a brief update of the latest trends. Blood Cells Mol Dis (2007) 0.86
Secondary solid cancer screening following hematopoietic cell transplantation. Bone Marrow Transplant (2015) 0.86
Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD. Bone Marrow Transplant (2014) 0.85
Cardiac effects of chronic graft-versus-host disease after stem cell transplantation. Tex Heart Inst J (2013) 0.85
Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism. Biol Blood Marrow Transplant (2012) 0.84
Impaired pulmonary immunity post-bone marrow transplant. Immunol Res (2011) 0.84
Second malignancies after autologous hematopoietic cell transplantation in children. Bone Marrow Transplant (2012) 0.84
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. ScientificWorldJournal (2014) 0.84
Transplantation conditioning regimens and outcomes after allogeneic hematopoietic cell transplantation in children and adolescents with acute lymphoblastic leukemia. Biol Blood Marrow Transplant (2012) 0.82
Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy. Health Phys (2012) 0.82
Immunological thought in the mainstream of cancer research: Past divorce, recent remarriage and elective affinities of the future. Oncoimmunology (2012) 0.81
Narrowband ultraviolet B phototherapy for the treatment of steroid-refractory and steroid-dependent acute graft-versus-host disease of the skin. J Am Acad Dermatol (2011) 0.81
Second primary glioblastoma multiforme following autologous hematopoietic stem cell transplantation in a patient with acute myelogenous leukemia. Cancer Res Treat (2011) 0.80
Therapeutic potential of growth factors in pulmonary emphysematous condition. Lung (2012) 0.80
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report. Biol Blood Marrow Transplant (2016) 0.79
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report. Biol Blood Marrow Transplant (2016) 0.79
Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study. Br J Cancer (2014) 0.79
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant (2008) 0.79
Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers. Support Care Cancer (2014) 0.79
Oral and dental late effects in survivors of childhood cancer: a Children's Oncology Group report. Support Care Cancer (2014) 0.79
Hematopoietic stem cell transplantation: a primer for the primary care physician. CMAJ (2004) 0.78
Risk of salivary gland cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Int J Radiat Oncol Biol Phys (2012) 0.78
Cryptococcal tongue lesion in a stem cell transplant patient: first reported case. Case Rep Otolaryngol (2012) 0.78
Novel management of acute or secondary biliary liver conditions using hepatically differentiated human dental pulp cells. Tissue Eng Part A (2014) 0.78
Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant (2011) 0.77
Expression and localization of aging markers in lacrimal gland of chronic graft-versus-host disease. Sci Rep (2013) 0.77
Prognostic understanding, quality of life and mood in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant (2015) 0.76
Survival of patients who develop solid tumors following hematopoietic stem cell transplantation. Bone Marrow Transplant (2015) 0.76
Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy. Leukemia (2014) 0.76
Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT. Bone Marrow Transplant (2015) 0.76
Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update. J Ovarian Res (2016) 0.76
Immune recovery after allogeneic hematopoietic stem cell transplantation: is it time to revisit how patients are monitored? Biol Blood Marrow Transplant (2012) 0.75
Concern p16 overexpression in malignant and premalignant lesions of the oral and esophageal mucosa following allogeneic hematopoietic stem cell transplantation. Head Neck Oncol (2012) 0.75
Effects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML Patients. J Clin Med (2015) 0.75
Neoplasms and transplantation - trading swords for plowshares. N Engl J Med (1997) 0.75
Management of oral Graft versus Host Disease with topical agents: A systematic review. Med Oral Patol Oral Cir Bucal (2016) 0.75
Incidence of second cancers after allogeneic hematopoietic stem cell transplantation using reduced-dose radiation. Blood (2009) 0.75
Radiation exposure from diagnostic procedures following allogeneic stem cell transplantation--how much is acceptable? Hematology (2013) 0.75
Glioblastoma Multiforme in a Post Allogeneic Stem Cell Transplant Patient. A Case Report and Literature Review of Post Transplant Neurological Tumors. Indian J Hematol Blood Transfus (2015) 0.75
Treatment of systemic sclerosis: potential role for stem cell transplantation. Stem Cells Cloning (2009) 0.75
Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters. Bone Marrow Transplant (2016) 0.75
Oral squamous cell carcinoma arising in a patient after hematopoietic stem cell transplantation with bisphosphonate-related osteonecrosis of the jaws. Case Rep Dent (2015) 0.75
Bronchial mucoepidermoid carcinoma after allogeneic bone marrow transplantation. J Clin Pathol (1997) 0.75
Clinical stages in patients with primary and subsequent cancers based on the czech cancer registry 1976-2005. ISRN Oncol (2013) 0.75
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 0.75
Eleven secondary cancers after hematopoietic stem cell transplantation using a total body irradiation-based regimen in 370 consecutive pediatric and adult patients. Springerplus (2013) 0.75
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Rising incidence of renal cell cancer in the United States. JAMA (1999) 9.57
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst (1993) 9.48
Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (2000) 8.96
Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med (1969) 6.54
A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med (1999) 5.82
Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res (1995) 5.72
Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials (2000) 5.37
Graft-versus-host disease. N Engl J Med (1991) 5.35
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science (1999) 5.09
Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst (1993) 5.07
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol (1997) 4.52
Lung cancer. Cancer (1995) 4.50
Snuff dipping and oral cancer among women in the southern United States. N Engl J Med (1981) 4.33
Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med (1987) 4.12
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies. J Natl Cancer Inst (1997) 3.89
Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst (1996) 3.76
Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med (2000) 3.72
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA (1986) 3.63
Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med (1988) 3.62
Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group. J Natl Cancer Inst (1997) 3.61
Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst (1993) 3.52
Risk of cancer in renal-transplant recipients. Lancet (1973) 3.36
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34
Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30
Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med (1994) 3.26
Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med (1986) 3.22
A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13
Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet (1977) 3.05
Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst (1995) 3.03
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood (1981) 3.03
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA (1997) 3.00
Clues to cancer etiology from studies of farmers. Scand J Work Environ Health (1992) 2.98
Risk of breast cancer following low-dose radiation exposure. Radiology (1979) 2.86
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Recent cancer trends in the United States. J Natl Cancer Inst (1995) 2.76
The canine major histocompatibility complex. Supertypic specificities defined by the primed lymphocyte test (PLT). Immunogenetics (1984) 2.72
Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA (1993) 2.71
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med (1990) 2.66
Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol (1998) 2.65
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
Random digit dialing in selecting a population-based control group. Am J Epidemiol (1984) 2.64
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
The emerging epidemic of melanoma and squamous cell skin cancer. JAMA (1989) 2.61
Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst (2001) 2.59
A population-based case-control study of childhood leukemia in Shanghai. Cancer (1988) 2.59
Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int J Radiat Oncol Biol Phys (1995) 2.58
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. Ann Intern Med (1996) 2.52
Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst (1969) 2.50
International trends and patterns of primary liver cancer. Int J Cancer (2001) 2.50
Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol (1991) 2.49
Mammographic densities and risk of breast cancer. Cancer (1991) 2.47
Residential radon exposure and lung cancer among nonsmoking women. J Natl Cancer Inst (1994) 2.45
Attributable risk: advantages of a broad definition of exposure. Am J Epidemiol (1994) 2.45
Geographic patterns of lung cancer: industrial correlations. Am J Epidemiol (1976) 2.45
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (1998) 2.43
Artificial sweeteners and human bladder cancer. Preliminary results. Lancet (1980) 2.42
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med (1989) 2.42
Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev (2002) 2.36
Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst (2000) 2.35
Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst (1995) 2.35
Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med (1992) 2.34